Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,030 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives.
Calapai F, Cardia L, Esposito E, Ammendolia I, Mondello C, Lo Giudice R, Gangemi S, Calapai G, Mannucci C. Calapai F, et al. Among authors: esposito e. Evid Based Complement Alternat Med. 2022 Nov 8;2022:3336516. doi: 10.1155/2022/3336516. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36397993 Free PMC article. Review.
Pharmacovigilance on cannabidiol as an antiepileptic agent.
Ammendolia I, Mannucci C, Cardia L, Calapai G, Gangemi S, Esposito E, Calapai F. Ammendolia I, et al. Among authors: esposito e. Front Pharmacol. 2023 Feb 10;14:1091978. doi: 10.3389/fphar.2023.1091978. eCollection 2023. Front Pharmacol. 2023. PMID: 36843933 Free PMC article.
Response to "Evaluating Adverse Events in Databases".
Calapai F, Mannucci C, Cardia L, Currò M, Calapai G, Esposito E, Ammendolia I. Calapai F, et al. Among authors: esposito e. Pharmacol Res Perspect. 2023 Oct;11(5):e01127. doi: 10.1002/prp2.1127. Pharmacol Res Perspect. 2023. PMID: 37589310 Free PMC article. No abstract available.
Pharmacovigilance of unlicensed cannabidiol in European countries.
Calapai F, Esposito E, Ammendolia I, Mannucci C, Calapai G, Currò M, Cardia L, Chinou I. Calapai F, et al. Among authors: esposito e. Phytother Res. 2024 Jan;38(1):74-81. doi: 10.1002/ptr.8028. Epub 2023 Oct 6. Phytother Res. 2024. PMID: 37800192
Editorial: Enteric inflammation and chronic diseases: Is there a link?
Marzocco S, Esposito G, Esposito E, Hassan STS. Marzocco S, et al. Among authors: esposito e, esposito g. Front Pharmacol. 2022 Oct 13;13:1018144. doi: 10.3389/fphar.2022.1018144. eCollection 2022. Front Pharmacol. 2022. PMID: 36313353 Free PMC article. No abstract available.
The Role of Nanotechnology in Spinal Cord Tumors.
Caffo M, Caruso G, Laera R, Curcio A, Cacciola F, Esposito E, Germanò A. Caffo M, et al. Among authors: esposito e. Adv Exp Med Biol. 2023;1394:193-207. doi: 10.1007/978-3-031-14732-6_12. Adv Exp Med Biol. 2023. PMID: 36587389
Correction: Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice.
Campolo M, Esposito E, Ahmad A, Di Paola R, Paterniti I, Cordaro M, Bruschetta G, Wallace JL, Cuzzocrea S. Campolo M, et al. Among authors: esposito e. J Neuroinflammation. 2024 May 28;21(1):139. doi: 10.1186/s12974-024-03131-6. J Neuroinflammation. 2024. PMID: 38807141 Free PMC article. No abstract available.
1,030 results